WuXi Biologics (Cayman) Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
63.17 | 217.72 | -70.98% | 74.41 | -15.1% |
| P/S |
|
12.61 | 5.55 | 127.34% |
|
|
| P/BV |
|
4.88 | 5.48 | -11.03% |
|
|
| P/FCF |
|
49.43 | 30.19 | 63.73% |
|
|
| Ev/Ebitda |
|
36.75 | 15.59 | 135.63% |
|
|
| Ev/S |
|
12.31 | 4.95 | 148.47% |
|
|
| Ev/FCF |
|
479.55 | 27.08 | 1670.73% |
|
|
| E/P |
|
0.1573 | 29.5 | -99.47% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
33.49 | 103.6 | -67.67% | 33.15 | +1.04% |
| ROE |
|
8.43 | 36.11 | -76.66% |
|
|
| ROA |
|
6.01 | 19.21 | -68.72% |
|
|
| ROIC |
|
11.15 | 13.96 | -20.13% |
|
|
| ROS |
|
19.96 | 12.87 | 55.12% |
|
|
| ROCE |
|
10.31 | 156.55 | -93.41% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.4035 | 1.12 | -64.09% | 0.6599 | -38.85% |
| Nеt Debt/Ebitda |
|
-0.8954 | 0.0983 | -1010.8% |
|
|
| Debt/Ratio |
|
0.0407 | 0.1997 | -79.62% |
|
|
| Debt/Equity |
|
0.2853 | 0.8861 | -67.81% |
|
|
| Debt/Net Income |
|
0.6772 | 37.54 | -98.2% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 5 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.16 | -100% | ||
| DSI |
|
0 | 0.6872 | -100% |
|
|
| Average dividend growth |
|
0 | -465.25 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 54.62 | -100% |
|
|
| Average percentage for payments |
|
130.35 | 179.18 | -27.25% |
|
|
| Difference from average difference in sector |
|
-5 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
327.6 | 60.27 | 443.55% | ||
| Growth impulse Ebitda in 5 years |
|
382.04 | 181.39 | 110.62% | ||
| Growth impulse Net Income in 5 years |
|
235.34 | 188.93 | 24.56% | ||
| Growth impulse FCF in 5 years |
|
-121.83 | 14.76 | -925.41% | ||
| Growth impulse EPS in 5 years |
|
1839.82 | 232.97 | 689.72% |
IP Score
5.44/10
